[1]
|
张鑫, 林岩松. 非远处转移性分化型甲状腺癌~(131)I治疗进展——2019年《ESMO临床实践指南: 甲状腺癌的诊断、治疗和随访》解读[J]. 中华核医学与分子影像杂志, 2020, 40(6): 343-350.
|
[2]
|
Kurtulmus, N., Ertas, B., Saglican, Y., et al. (2016) BRAFV600E Mutation: Has It a Role in Cervical Lymph Node Metastasis of Papillary Thy-roid Cancer? European Thyroid Journal, 5, 195-200. https://doi.org/10.1159/000448112
|
[3]
|
Khan, M.S., Qadri, Q., Makhdoomi, M.J., et al. (2020) RET/PTC Gene Rearrangements in Thyroid Carcinogenesis: Assessment and Clinico-Pathological Correlations. Pathology and Oncology Research, 26, 507-513.
https://doi.org/10.1007/s12253-018-0540-3
|
[4]
|
赫捷, 李进, 程颖, 等. 中国临床肿瘤学会(CSCO)分化型甲状腺癌诊疗指南2021[J]. 肿瘤预防与治疗, 2021, 34(12): 1164-1201.
|
[5]
|
陈立波, 丁勇, 关海霞, 等. 中国临床肿瘤学会(CSCO)持续/复发及转移性分化型甲状腺癌诊疗指南-2019[J]. 肿瘤预防与治疗, 2019, 32(12): 1051-1080.
|
[6]
|
Hepworth, E. and Hinton, S.D. (2021) Pseudophosphatases as Regulators of MAPK Signaling. In-ternational Journal of Molecular Sciences, 22, 12595. https://doi.org/10.3390/ijms222212595
|
[7]
|
Iravani, A., Solomon, B., Pattison, D.A., et al. (2019) Mitogen-Activated Protein Kinase Pathway Inhibition for Redifferentiation of Radioiodine Refractory Differentiated Thyroid Cancer: An Evolving Protocol. Thyroid, 29, 1634-1645.
https://doi.org/10.1089/thy.2019.0143
|
[8]
|
王也, 笪冀平, 杨磊, 等. 甲状腺细针穿刺8644例标本即时定量PCR法检测BRAF基因突变的结果分析[J]. 中华病理学杂志, 2019, 48(11): 873-877.
|
[9]
|
Kim, B.A., Jee, H.G., Yi, J.W., et al. (2017) Expression Profiling of a Human Thyroid Cell Line Stably Expressing the BRAFV600E Mutation. Cancer Genomics Proteomics, 14, 53-67. https://doi.org/10.21873/cgp.20018
|
[10]
|
Espenbetova, M., Krykpayeva, A., Zamanbekova, Z., et al. (2021) Analysis of the Association of BRAFV600E Mutation and Ki-67 Overexpression with Clinical and Pathological Characteristics in Papillary Thyroid Cancer. Radiation and Environmental Biophysics, 60, 233-241. https://doi.org/10.1007/s00411-021-00904-y
|
[11]
|
宋创业, 孟艳林, 严丽, 等. 炎症指标、BRAFV600E与甲状腺乳头状癌的相关性研究[J]. 中国现代普通外科进展, 2021, 24(10): 834-837.
|
[12]
|
Liu, G., Yuan, C., Ma, J., et al. (2021) Influence of Immune Microenvironment on Diagnosis and Prognosis of Head and Neck Squamous Cell Carcinoma. Frontiers in Oncology, 11, Article ID: 604784.
https://doi.org/10.3389/fonc.2021.604784
|
[13]
|
Motomura, T., Shirabe, K., Mano, Y., et al. (2013) Neutro-phil-Lymphocyte Ratio Reflects Hepatocellular Carcinoma Recurrence after Liver Transplantation via Inflammatory Microenvironment. Journal of Hepatology, 58, 58-64.
https://doi.org/10.1016/j.jhep.2012.08.017
|
[14]
|
Kantola, T., Klintrup, K., Väyrynen, J.P., et al. (2012) Stage-Dependent Alterations of the Serum Cytokine Pattern in Colorectal Carcinoma. British Journal of Cancer, 107, 1729-1736. https://doi.org/10.1038/bjc.2012.456
|
[15]
|
Avci, N., Deligonul, A., Tolunay, S., et al. (2015) Prognos-tic Impact of Tumor Lymphocytic Infiltrates in Patients with Breast Cancer Undergoing Neoadjuvant Chemotherapy. Journal BUON, 20, 994-1000.
|
[16]
|
Song, M.K., Chung, J.S., Seol, Y.M., et al. (2010) Influence of Low Absolute Lymphocyte Count of Patients with Nongerminal Center Type Diffuse Large B-Cell Lymphoma with R-CHOP Therapy. Annals of Oncology, 21, 140-144.
https://doi.org/10.1093/annonc/mdp505
|
[17]
|
Zhang, X., Li, S., Wang, J., et al. (2021) Relationship between Serum Inflammatory Factor Levels and Differentiated Thyroid Carcinoma. Technology in Cancer Research & Treatment, 20, 1-8.
https://doi.org/10.1177/1533033821990055
|
[18]
|
Ceylan, Y., Oral, A., et al. (2019) The Correlation of Clinicopathological Findings and Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios in Papillary Thyroid Carcinoma. Molecular Imaging and Radionuclide Therapy, 28, 15-20.
https://doi.org/10.4274/mirt.galenos.2018.60490
|
[19]
|
Chen, W., Wei, T., Li, Z., et al. (2020) Association of the Preoperative Inflammation-Based Scores with TNM Stage and Recurrence in Patients with Papillary Thyroid Carcinoma: A Retrospective, Multicenter Analysis. Cancer Management and Research, 12, 1809-1818. https://doi.org/10.2147/CMAR.S239296
|
[20]
|
Ari, A. and Gunver, F. (2019) Comparison of Neutro-phil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio in Patients with Thyroiditis and Papillary Tumors. Journal of International Medical Research, 47, 2077-2083.
https://doi.org/10.1177/0300060519838392
|
[21]
|
Prodromidou, A. andreakos, P., Kazakos, C., et al. (2017) The Diagnostic Efficacy of Platelet-to-Lymphocyte Ratio and Neutrophil-to-Lymphocyte Ratio in Ovarian Cancer. In-flammation Research, 66, 467-475.
https://doi.org/10.1007/s00011-017-1026-6
|
[22]
|
Temur, I., Kucukgoz Gulec, U., Paydas, S., et al. (2018) Prog-nostic Value of Pre-Operative Neutrophil/Lymphocyte Ratio, Monocyte Count, Mean Platelet Volume, and Plate-let/Lymphocyte Ratio in Endometrial Cancer. The European Journal of Obstetrics & Gynecology and Reproductive Biology, 226, 25-29.
https://doi.org/10.1016/j.ejogrb.2018.05.028
|
[23]
|
Cho, J.S., Park, M.H., Ryu, Y.J., et al. (2015) The Neutrophil to Lymphocyte Ratio Can Discriminate Anaplastic Thyroid Cancer against Poorly or Well Differentiated Cancer. Annals of Surgical Treatment and Research, 88, 187-192.
https://doi.org/10.4174/astr.2015.88.4.187
|
[24]
|
Shrestha, B.L., Kc, A.K., Rajbhandari, P., et al. (2021) Does the Preoperative Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio Associate with Clinic-pathological Characteristics in Papillary Carcinoma of Thyroid. Kathmandu University Medical Journal (KUMJ), 19, 225-229. https://doi.org/10.3126/kumj.v19i2.49651
|
[25]
|
Huang, Y., Liu, Y., Mo, G., et al. (2022) Inflammation Markers Have Important Value in Predicting Relapse in Patients with Papillary Thyroid Carcinoma: A Long-Term Follow-Up Retrospective Study. Cancer Control, 29.
https://doi.org/10.1177/10732748221115236
|
[26]
|
林琳, 李娜, 吴丽娜, 秦晓松. 外周血NLR、MLR、SII在甲状腺髓样癌中的应用价值[J]. 现代肿瘤医学, 2022, 30(10): 1753-1757.
|
[27]
|
Gong, W., Yang, S., Yang, X. and Guo, F. (2016) Blood Preoperative Neutrophil-to-Lymphocyte Ratio Is Correlated with TNM Stage in Patients with Papillary Thyroid Cancer. Clinics (Sao Paulo), 71, 311-314.
https://doi.org/10.6061/clinics/2016(06)04
|
[28]
|
宋创业, 孟艳林, 刘冰, 等. 中性粒细胞淋巴细胞计数比值和血小板淋巴细胞计数比值与甲状腺微小乳头状癌中央区淋巴结转移的关系[J]. 中华肿瘤杂志, 2021, 43(9): 944-948.
|
[29]
|
Gao, R., Zhang, Y., Kang, Y., et al. (2020) Glycyrrhizin Inhibits PEDV Infection and Proinflammatory Cytokine Secretion via the HMGB1/TLR4-MAPK p38 Pathway. International Journal of Molecular Sciences, 21, 2961.
https://doi.org/10.3390/ijms21082961
|
[30]
|
Lin, T.C., Wang, K.H., Chuang, K.H., et al. (2021) Interleukin-33 Promotes Invasiveness of Human Ovarian Endometriotic Stromal Cells through the ST2/MAPK/MMP-9 Pathway Ac-tivated by 17β-Estradiol. Taiwanese Journal of Obstetrics and Gynecology, 60, 658-664. https://doi.org/10.1016/j.tjog.2021.05.013
|
[31]
|
刘凤磊, 何欣, 常守凤, 等. 甲状腺乳头状癌BRAF V600E突变与肿瘤相关成纤维细胞的关系[J]. 临床与实验病理学杂志, 2021, 37(7): 833-836.
|
[32]
|
Sulaieva, O., Chernenko, O., Selesnov, O., et al. (2020) Mechanisms of the Impact of Hashimoto Thyroiditis on Papillary Thyroid Carcinoma Progression: Relationship with the Tumor Immune Microenvironment. Endocrinology and Metabolism (Seoul), 35, 443-455. https://doi.org/10.3803/EnM.2020.35.2.443
|
[33]
|
Rios, L., Cloete, B. and Mowla, S. (2020) Activa-tion-Induced Cytidine Deaminase: In Sickness and in Health. Journal of Cancer Research and Clinical Oncology, 146, 2721-2730. https://doi.org/10.1007/s00432-020-03348-x
|
[34]
|
Kumar, R. and Evans, T. (2019) Activation-Induced Cytidine Deaminase Regulates Fibroblast Growth Factor/Extracellular Signal-Regulated Kinases Signaling to Achieve the Naïve Pluripotent State during Reprogramming. Stem Cells, 37, 1003-1017. https://doi.org/10.1002/stem.3023
|
[35]
|
Godsmark, G., De Souza Rios, L.A. and Mowla, S. (2021) Activa-tion-Induced Cytidine Deaminase Promotes Proliferation and Enhances Chemoresistance and Migration in B-Cell Lymphoma. Anticancer Research, 41, 237-247.
https://doi.org/10.21873/anticanres.14770
|
[36]
|
Che, Z., Fan, J., Zhou, Z., et al. (2020) Activation-Induced Cytidine Deaminase Expression Facilitates the Malignant Phenotype and Epithelial-to-Mesenchymal Transition in Clear Cell Renal Cell Carcinoma. DNA and Cell Biology, 39, 1299-1312. https://doi.org/10.1089/dna.2019.5119
|
[37]
|
Muñoz, D.P., Lee, E.L., Takayama, S., et al. (2013) Activation-Induced Cytidine Deaminase (AID) Is Necessary for the Epithelial-Mesenchymal Transition in Mammary Epithelial Cells. Proceedings of the National Academy of Sciences of the United States of America, 110, E2977-E2986. https://doi.org/10.1073/pnas.1301021110
|
[38]
|
Ascierto, P.A., Schadendorf, D., Berking, C., et al. (2013) MEK162 for Patients with Advanced Melanoma Harbouring Nras or Val600 BRAF Mutations: A Non-Randomised, Open-Label Phase 2 Study. The Lancet Oncology, 14, 249-256.
https://doi.org/10.1016/S1470-2045(13)70024-X
|
[39]
|
Yan, H., Fernandez, M., Wang, J., et al. (2020) B Cell Endosomal RAB7 Promotes TRAF6 K63 Polyubiquitination and NF-κB Activation for Antibody Class-Switching. The Journal of Immunology, 204, 1146-1157.
https://doi.org/10.4049/jimmunol.1901170
|
[40]
|
Chen, G., Gao, Y., Wang, G., Dai, G. and Tong, L. (2020) MiR-145 Inhibits the Migration and Invasion of Papillary Thyroid Carcinoma Cells through NF-κB Pathway Regulation. Journal of Cellular Biochemistry, 121, 3325-3332.
https://doi.org/10.1002/jcb.29604
|
[41]
|
Pires, B.R.B., Silva, R., Ferreira, G.M., et al. (2018) NF-kappaB: Two Sides of the Same Coin. Genes (Basel), 9, 24.
https://doi.org/10.3390/genes9010024
|
[42]
|
周德华. BRAF~(V600E)或RET/PTC通过调节NF-κB信号通路来促进甲状腺乳头状癌增殖、迁移及细胞因子表达[D]: [博士学位论文]. 广州: 南方医科大学, 2018.
|